The period opens with the US–Singapore Free Trade Agreement, implemented in 2004. Beyond liberalising trade, it introduced intellectual property standards going beyond what the World Trade Organization required: patent term extensions to compensate for examination delays, five-year data exclusivity for pharmaceutical test data, and stronger enforcement. Similar provisions later appeared in Singapore’s agreements with Australia, Japan and Korea.
Singapore’s own patenting activity rose sharply. Applications per million population climbed from the late 1990s to 2005, and filings received by the Intellectual Property Office of Singapore surged after 2010, approaching 10,000 a year by 2020. Companies dominate: eight of the ten largest applicants are firms, led by Lenovo (Singapore) with 2,885 patent families. A*STAR and the National University of Singapore also rank in the top ten, showing that public research institutions remain meaningful contributors alongside private enterprise.
The technology mix shifted with it. Electrical engineering shows the strongest long-term growth, reflecting Singapore’s electronics base, while chemistry gained ground after 2015 alongside pharmaceuticals and life sciences. Among emerging fields, semiconductor patenting peaked around 2010 before tapering, biotechnology and clean technology expanded through the mid-2010s, artificial intelligence filings surged after 2015, and quantum technology remains small but steady.
Bilateral collaboration follows two distinct patterns. Patent families co-invented by US- and Singapore-based inventors grew steadily, from fewer than 100 a year in the late 1990s to more than 300 by 2020, the highest level recorded. Co-applications, where firms jointly hold the filing, behaved differently: they peaked at around 450 families in 2011–2012 before falling below 100 later in the decade, as companies consolidated portfolios in larger jurisdictions. A modest recovery has since emerged in artificial intelligence, clean technology and life sciences.
Singapore’s partnerships have diversified geographically as well. The United States remains its most important collaborator, but its share of Singapore’s international co-inventions fell from around half in the late 1990s to roughly 30 per cent by 2020, as China, Japan, Germany, Taiwan and India became more prominent. Within ASEAN, co-invention with Singapore remains limited, with Malaysia the most active partner.
Singapore–US innovation ties have evolved from a strong base in semiconductors into a much broader technology collaboration. These descriptive patterns document changes in collaboration; they do not establish that the 2004 US–Singapore Free Trade Agreement caused the subsequent growth in innovation. The policy implication is that strong intellectual property institutions and international openness can help connect Singapore to global innovation networks by giving partners greater confidence to share knowledge and undertake joint research. Capturing more value from these connections also requires investment in domestic research skills and in local firms’ ability to absorb and commercialise new technologies. In artificial intelligence, biotechnology and clean technology, closer collaboration between local firms, universities and international R&D partners could help turn shared research into products and capabilities developed in Singapore.
Researchers: BANH, Thi Hang, GE, Yixuan
